You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 15, April 15, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  This Week in JAMA
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

This Week in JAMA

JAMA. 2009;301(15):1507.

DIABETES

A JAMA THEME ISSUE

Edited by Catherine D. DeAngelis, MD, MPH, David S. Cooper, MD, and Phil B. Fontanarosa, MD, MBA


Coronary Artery Disease Screening in Type 2 Diabetes

In the Detection of Ischemia in Asymptomatic Diabetics study, the investigators assessed whether routine screening for coronary artery disease with adenosine-stress radionuclide myocardial perfusion imaging (MPI) identifies patients with type 2 diabetes who are at high risk of cardiac events and whether such identification influences patients' cardiac outcomes. Over a mean (SD) follow-up of 4.8 (0.9) years, Young and colleagues found that cardiac event rates were low and not significantly reduced by MPI screening of asymptomatic patients.


Figure 90011FA

(SEE ARTICLE)


Hypoglycemia and Mortality in Acute MI

Both hyperglycemia and hypoglycemia increase the risk of mortality among patients with acute myocardial infarction (MI). Whether episodic hypoglycemia from glucose-lowering therapy is harmful to patients with acute MI remains unresolved. Kosiborod and colleagues analyzed data from a retrospective cohort of patients with acute MI who were hyperglycemic when admitted to the hospital and found that the mortality risk associated with hypoglycemia was limited to patients who developed hypoglycemia spontaneously. Insulin-related hypoglycemia was not associated with a higher mortality risk.

(SEE ARTICLE)


Hypoglycemic Episodes and Dementia Risk

An association between severe hypoglycemia and impaired cognitive function has been reported among children and young adults with type 1 diabetes. Whether hypoglycemia severe enough to require hospitalization is associated with dementia risk among older patients with type 2 diabetes is not known. In an analysis of longitudinal data from patients with type 2 diabetes and a mean age of 65 years, Whitmer and colleagues found that a history of 1 or more severe hypoglycemic episodes was associated with an increased risk of dementia.

(SEE ARTICLE)


C-Peptide Levels After Stem Cell Transplant

Previously, Couri and colleagues reported that 15 patients with newly diagnosed type 1 diabetes who underwent autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) achieved insulin independence. In this issue, the authors report results from an expanded cohort of 23 patients who underwent HSCT. During a mean 29.8 month follow-up (range, 7-58 months), the authors found that 20 patients became insulin-free, 12 of whom remained insulin independent with good glycemic control for a mean of 31 months. To investigate whether insulin independence is due to preservation of beta-cell mass rather than dietary and exercise changes associated with intensive medical care following transplantation, the authors analyzed C-peptide levels—an indirect measure of viable beta-cell function—and found that C-peptide levels increased significantly following HSCT transplantation.

(SEE ARTICLE)


Pancreatic Islets and Diabetes Research

Human pancreatic islets are a critical resource in investigations of the biology and treatment of diabetes. Kaddis and colleagues reviewed data collected by the national Islet Resource Consortium and report their findings relating to the supply and demand for pancreatic islets, the funding and scientific impact of islet studies, and the operation of an islet distribution program. The authors discuss the clinical utility of human islets and alternatives to human islet preparations for research applications.

(SEE ARTICLE)


A Piece of My Mind

"Does failure to check an HBA1c level mean I am a worse physician?" From "The Tyranny of the Measuring Cup."

(SEE ARTICLE)


Medical News & Perspectives

Scientists hope islet cell transplantation or an artificial pancreas may one day improve treatment of diabetes.

(SEE ARTICLE)


Commentaries

Can diabetes be cured?

(SEE ARTICLE)

Bariatric surgery and diabetes

(SEE ARTICLE)

Public health response to diabetes

(SEE ARTICLE)


CLINICIAN'S CORNER

Glucose control in type 2 diabetes

(SEE ARTICLE)


Editorial

Progress in diabetes research: what's next?

(SEE ARTICLE)


Readers Respond

How would you manage a 51-year-old woman with an acute onset of facial pressure, rhinorrhea, and tooth pain? Go to www.jama.com to read the case and submit your response, which may be selected for online publication. Submission deadline is April 29.


JAMA Patient Page

For your patients: Information about diabetes.

(SEE ARTICLE)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.